Skip to content

Limbach Holdings, Inc. LMB Indefinite-Lived Research and Development Assets

Indefinite-Lived Research and Development Assets at other companies

HTF
Heartflow, Inc. Common StockHTFL
$15.41M-25.5%
Photronics logo
PhotronicsPLAB
$3.9M+43.5%
KEE
Keel Infrastructure Corp. Common StockKEEL
$2.19M-50.8%
Tarsus Pharmaceuticals, Inc. logo
Tarsus Pharmaceuticals, Inc.TARS
$7.96M-63.4%
Lantheus Holdings logo
Lantheus HoldingsLNTH
$6.19M-79.2%
BlackSky Technology logo
BlackSky TechnologyBKSY
$8.38M-29.4%

Other financials

Income statement

See full
Revenue$138.9M+4.3%
Gross profit$31.2M-15.1%
Operating income$1.1M-85.7%
Net income$4.4M-57.1%
EPS (diluted)$0.36-57.6%

Balance sheet

See full
Cash & equivalents$15.8M-58.5%
Total debt$101.1M+54.4%
Total equity$196.3M+21.8%
Total assets$377.0M+12.1%

Cash flow

See full
Operating cash flow-$7.8M-449%
CapEx$407.0K-81.7%
Free cash flow-$8.2M-74,800%

Valuation

See full
Market cap$957.02M-40.3%
Enterprise value$1.04B-36.0%
P/E28.8×-19.0×
P/S1.5×-1.5×

Profitability

See full
Gross margin25.1%-3.0pp
Operating margin6.5%-1.0pp
Net margin5.1%-1.2pp
FCF margin5.2%-1.6pp

Returns & leverage

See full
Return on equity18.6%-4.8pp
Debt / equity0.5×+0.1×
Current ratio1.7×+0.2×

Where this comes from

Reported directly by Limbach Holdings, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IndefiniteLivedIntangibleAssetsExcludingGoodwill.

The official record: Limbach Holdings, Inc.’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Limbach Holdings, Inc.'s indefinite-lived research and development assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Limbach Holdings, Inc.'s indefinite-lived research and development assets?
Limbach Holdings, Inc. (LMB) reported indefinite-lived research and development assets of $9.96M in Q1 2026.
How has Limbach Holdings, Inc.'s indefinite-lived research and development assets changed year-over-year?
Limbach Holdings, Inc.'s indefinite-lived research and development assets decreased by 0.0% year-over-year, from $9.96M to $9.96M.
What is the long-term trend for Limbach Holdings, Inc.'s indefinite-lived research and development assets?
Over 5 years (2020 to 2025), Limbach Holdings, Inc.'s indefinite-lived research and development assets has grown at a 0.0% compound annual growth rate (CAGR), from $9.96M to $9.96M.